Century Therapeutics, Inc. — Director's Dealing 2024

Nov 5, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Century Therapeutics, Inc. (IPSC)
CIK: 0001850119
Period of Report: 2024-11-01

Reporting Person: Carr Douglas (SVP Finance & Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-11-01	Common Stock	F	16611	$1.26	Disposed	317430	Direct
2024-11-04	Common Stock	S	283	$1.227	Disposed	317147	Direct

Footnotes

F1: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

F2: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.